Pulse Biosciences, Inc (NASDAQ:PLSE) is expected to report second quarter earnings results, after market close, on Monday 10th August 2020.
Analysts polled by Thomson Reuters anticipate second quarter loss of $ 0.5 per share.
Looking ahead, the full year loss are expected at $ 2.07 per share.
Previous Quarter Performance
Pulse Biosciences, Inc posted loss for the first quarter of $ 0.57 per share, from the revenue of . The quarterly revenues compared with the same quarter last year. Wall street analysts are predicting, loss of $ 0.47 per share The bottom line results missed street analysts by $ 0.1 or 21.28 percent, at the same time, top line results analysts by $ 1,273.25 million or .
Stock Performance
According to the previous trading day, closing price of PLSE was $ 11.13, representing a 117.81 % increase from the 52 week low of $ 5.11 and a 36.22 % decrease over the 52 week high of $ 17.45.
The company has a market capital of $ 279.91 million and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Conference Call
Pulse Biosciences, Inc will be hosting a conference call at 4:30 PM eastern time on 10th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.pulsebiosciences.com
Pulse Biosciences, Inc. operates as a clinical stage medical therapy company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications.
